Inquiry Basket
Loading ......
Filter By Product Search for
Kynurenine
Kynurenine Full Name
Kynurenine
Kynurenine Introduction
Kynurenine is a central metabolite in the degradation of tryptophan, forming the backbone of the kynurenine pathway, which accounts for the majority of tryptophan catabolism in mammals. This pathway begins with the oxidation of tryptophan by enzymes such as indoleamine 2,3-dioxygenase (IDO) or tryptophan 2,3-dioxygenase (TDO), generating N-formylkynurenine, which is rapidly converted into L-kynurenine. Unlike many metabolic intermediates that serve purely as biochemical stepping stones, kynurenine is biologically active and highly dynamic, acting as a precursor to several downstream metabolites with distinct and sometimes opposing functions. These include kynurenic acid (KYNA), known for its neuroprotective properties, and quinolinic acid (QUIN), which is associated with neurotoxicity. The ability of kynurenine to cross the blood–brain barrier further amplifies its systemic importance, linking peripheral metabolism with central nervous system function.
Functionally, kynurenine and its downstream metabolites regulate a wide range of physiological processes, particularly in the nervous and immune systems. In the brain, kynurenine-derived metabolites modulate neurotransmission by interacting with glutamatergic and cholinergic receptors, thereby influencing synaptic plasticity, cognition, and neuronal survival. Kynurenic acid, for example, acts as an antagonist of excitatory glutamate receptors and contributes to neuroprotection under conditions of excessive stimulation. In parallel, other branches of the pathway produce metabolites that promote oxidative stress and excitotoxicity, highlighting a tightly controlled balance within the pathway. Beyond neurobiology, kynurenine also functions as an immune regulator. It can activate the aryl hydrocarbon receptor (AhR), shaping immune cell differentiation and promoting immune tolerance. Emerging evidence further suggests that upstream metabolites such as N-formylkynurenine may participate in previously unrecognized branches of the pathway, including mechanisms that scavenge reactive cellular components, adding another layer of complexity to its biological roles.
Dysregulation of kynurenine metabolism has been increasingly linked to a broad spectrum of diseases, making it a critical focus for both basic research and therapeutic development. In neurological and psychiatric disorders, such as schizophrenia, Alzheimer's disease, and depression, imbalances between neuroprotective and neurotoxic kynurenine metabolites are thought to contribute to disease progression through mechanisms involving excitotoxicity, inflammation, and synaptic dysfunction. In conditions like traumatic brain injury, activation of the kynurenine pathway is associated with both harmful inflammatory responses and potential compensatory neuroprotective effects, reflecting its dual role in disease pathology. Moreover, in cancer and chronic inflammatory diseases, elevated kynurenine levels—often driven by increased IDO activity—can suppress anti-tumor immunity by promoting immune tolerance, allowing tumor cells to evade immune surveillance. Enzymes such as kynurenine 3-monooxygenase (KMO), which direct the pathway toward the production of neurotoxic metabolites, have therefore emerged as promising therapeutic targets. Modulating this pathway offers a strategic opportunity to rebalance metabolic outputs, reduce pathological damage, and improve outcomes across a range of complex diseases.
Alternate Names for Kynurenine
L-kynurenine; 2922-83-0; (S)-2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid; Kynurenine, L-; 3-Anthraniloyl-L-alanine
Loading ......
